Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Austin I Kim, M.D.

Concepts (30)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Austin Kim's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Austin Kim has written about over time.
Lymphoma, Mantle-Cell, 1 publications between 2020 and 2020, average publication date March 2020. Hematopoietic Stem Cell Transplantation, 4 publications between 2019 and 2021, average publication date April 2020. Transplantation, Autologous, 4 publications between 2019 and 2021, average publication date April 2020. Hodgkin Disease, 2 publications between 2019 and 2021, average publication date July 2020. Lymphoma, Large B-Cell, Diffuse, 2 publications between 2020 and 2021, average publication date August 2020. Antineoplastic Combined Chemotherapy Protocols, 2 publications between 2020 and 2021, average publication date December 2020. Histiocytes, 1 publications between 2021 and 2021, average publication date March 2021. T-Lymphocytes, 1 publications between 2021 and 2021, average publication date March 2021. Tumor Escape, 1 publications between 2021 and 2021, average publication date March 2021. Benzamides, 1 publications between 2021 and 2021, average publication date September 2021. Leukemia, Lymphocytic, Chronic, B-Cell, 1 publications between 2021 and 2021, average publication date September 2021. Pyrazines, 1 publications between 2021 and 2021, average publication date September 2021. Sulfonamides, 1 publications between 2021 and 2021, average publication date September 2021.

To see the data from this visualization as text, click here.
Kim's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (30)
Explore
_
Co-Authors (33)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.